Evidence map›Paper›PMID 41087540›Full record

ArticleNPJ precision oncology2025

RadGLO: an interactive platform for radiomic feature analysis and prognostic modeling in glioma.

Kavita Kundal, K Divya Rani, Vinodini D, Neeraj Kumar, Rahul Kumar

Abstract read
In one paragraph

Article in NPJ precision oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kavita KundalDepartment of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India.
K Divya RaniDepartment of Radio-diagnosis, MNJ Institute of Oncology and Regional Cancer Center, Hyderabad, Telangana, India.
Vinodini DDepartment of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India.
Neeraj KumarDepartment of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India.
Rahul KumarDepartment of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana, India. rahulk@bt.iith.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Radiomic features, quantitative descriptors of tumor shape, texture, and intensity derived from MRI serve as powerful non-invasive biomarkers for glioma characterization and prognosis. We present Radiology of Glioma (RadGLO), an interactive platform that leverages these features across multi-institutional datasets (TCGA, UCSF, UPENN) to support grade-wise analysis, gene correlation, and survival prediction. RadGLO integrates two in-house developed modules, RaSPr for risk stratification and TumorVQ for region-specific tumor volume quantification, which also supports user-uploaded MRI data. By enabling personalized prognosis and aiding treatment planning, RadGLO offers a valuable resource that is openly accessible at https://project.iith.ac.in/cgntlab/radglo/ .

Identifiers

PMID41087540
PMCPMC12521371

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.